Wilson Totten, chief executive of ProStrakan, yesterday said he was confident the Scottish specialist drug company would break into the black during 2009, following its push into the lucrative US market.
Wilson Totten, chief executive of ProStrakan, yesterday said he was confident the Scottish specialist drug company would break into the black during 2009, following its push into the lucrative US market.
Wilson Totten, chief executive of ProStrakan, yesterday said he was confident the Scottish specialist drug company would break into the black during 2009, following its push into the lucrative US market.